LeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans Quarterly Dividend of $0.16

LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) announced a quarterly dividend on Thursday, October 31st, Zacks reports. Investors of record on Thursday, November 21st will be given a dividend of 0.16 per share by the medical instruments supplier on Thursday, December 5th. This represents a $0.64 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Thursday, November 21st.

LeMaitre Vascular has increased its dividend by an average of 13.8% per year over the last three years and has raised its dividend every year for the last 13 years. LeMaitre Vascular has a dividend payout ratio of 31.1% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect LeMaitre Vascular to earn $2.09 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 30.6%.

LeMaitre Vascular Trading Up 7.3 %

NASDAQ:LMAT traded up $6.49 during mid-day trading on Friday, hitting $94.88. The company's stock had a trading volume of 343,645 shares, compared to its average volume of 105,134. LeMaitre Vascular has a fifty-two week low of $45.96 and a fifty-two week high of $101.67. The company has a market capitalization of $2.13 billion, a price-to-earnings ratio of 51.85, a P/E/G ratio of 2.32 and a beta of 0.89. The stock has a fifty day moving average of $89.59 and a 200-day moving average of $83.11.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.05. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.39%. The firm had revenue of $54.82 million during the quarter, compared to analyst estimates of $53.50 million. During the same quarter in the prior year, the business posted $0.33 earnings per share. The company's quarterly revenue was up 15.6% compared to the same quarter last year. On average, equities analysts anticipate that LeMaitre Vascular will post 1.86 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on LMAT. Barrington Research raised their price target on shares of LeMaitre Vascular from $92.00 to $93.00 and gave the company an "outperform" rating in a report on Friday. Cantor Fitzgerald began coverage on shares of LeMaitre Vascular in a report on Tuesday, October 15th. They issued a "neutral" rating and a $96.00 price target for the company. Oppenheimer reissued an "outperform" rating and issued a $93.00 price target (up previously from $90.00) on shares of LeMaitre Vascular in a report on Friday. JMP Securities raised their price target on shares of LeMaitre Vascular from $77.00 to $100.00 and gave the company a "market outperform" rating in a report on Tuesday, August 20th. Finally, StockNews.com lowered shares of LeMaitre Vascular from a "buy" rating to a "hold" rating in a report on Tuesday, August 27th. Three analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, LeMaitre Vascular has an average rating of "Moderate Buy" and an average target price of $94.57.

Insider Transactions at LeMaitre Vascular

In other news, Director David B. Roberts sold 3,063 shares of the business's stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $82.07, for a total transaction of $251,380.41. Following the transaction, the director now directly owns 14,114 shares in the company, valued at $1,158,335.98. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 10.79% of the stock is owned by company insiders.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.